CHAM
ONC icon

Clear Harbor Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

Clear Harbor Asset Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,608
Closed -$548K – 487
2025
Q3 		$548K Buy
+1,608
New +$488K 0.04% 275
2025
Q2 		– Sell
-1,638
Closed -$446K – 441
2025
Q1 		$446K Buy
1,638
+67
+4% +$15.7K 0.04% 280
2024
Q4 		$290K Hold
1,571
– – 0.02% 316
2024
Q3 		$353K Hold
1,571
– – 0.03% 276
2024
Q2 		$224K Hold
1,571
– – 0.02% 321
2024
Q1 		$246K Buy
1,571
+416
+36% +$67K 0.02% 315
2023
Q4 		$208K Buy
+1,155
New +$209K 0.02% 323

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Clear Harbor Asset Management's ONC Position: Q4 2025 in Review

Clear Harbor Asset Management sold out of BeOne Medicines Ltd (ONC) in Q4 2025, closing a stake of 1,608 shares — an estimated $548K sold.

Clear Harbor Asset Management first reported a position in ONC in Q4 2023 and held it in 7 quarters. The position peaked at $548K in Q3 2025. 286 funds tracked by Wall St. Rank hold ONC as of Q4 2025.

  • Clear Harbor Asset Management reported no remaining BeOne Medicines Ltd position as of Q4 2025 after selling out during the quarter.
  • Clear Harbor Asset Management sold 1,608 BeOne Medicines Ltd shares in Q4 2025, an estimated $548K.
  • Clear Harbor Asset Management first reported a position in BeOne Medicines Ltd in Q4 2023 and held it in 7 quarters.
  • Clear Harbor Asset Management's BeOne Medicines Ltd position peaked at $548K in Q3 2025.
  • 286 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2025.

Based on Clear Harbor Asset Management's 13F filing for Q4 2025, filed 10 Feb 2026.